| 12/10/2024 | CLHY | Market Commentary: Barnes Group, Signant, Ascensus, EG Group, CHG Healthcare, Veritext, Epicor, Quickbase break
|
| 12/4/2024 | CLHY | Market Commentary: TransUnion breaks; Nord Anglia, StepStone updated; Internet Brands, OYO and more set talk
|
| 5/20/2024 | BKHY | Moody’s gives Epicor facilities B2
|
| 5/17/2024 | BKHY | S&P assigns B- to Epicor loans
|
| 8/15/2023 | CLHY | Market Commentary: Tenneco, Access CIG, ASGN, Epicor break; Axalta, AppLovin, Lakeshore Learning updated
|
| 8/14/2023 | CLHY | Market Commentary: Epicor revised; US Foods, CHG, Tecta, Heartland Dental, Lakeshore and Liquid Tech set talk
|
| 8/8/2023 | CLHY | Market Commentary: H.B. Fuller breaks; Clear Channel up with planned paydown; ADT bid better on asset sale
|
| 8/7/2023 | CLHY | Market Commentary: Greystar, Generation Bridge break, Tenneco, AZZ, Four Seasons, Tronox and more set talk
|
| 1/26/2021 | CLHY | Market Commentary: IXS, First Advantage, KIK break; System One revised; Endurance, RV, MHS, symplr accelerated
|
| 1/21/2021 | CLHY | Market Commentary: Jane, Ineos, Westinghouse, Murphy break; Careismatic, First Advantage, Vestcom tweaked
|
| 10/13/2020 | BKCVHY | Moody’s rates Epicor B3
|
| 8/31/2020 | CLHY | Market Commentary: Epicor Software first- and second-lien term loans steady with buyout news
|
| 7/23/2020 | CLHY | Market Commentary: Ryan Specialty, Epicor Software, First Brands break for trading; Tosca accelerates deadline
|
| 7/22/2020 | CLHY | Market Commentary: Alion Science frees up; Epicor updates terms; First Brands lifts loan size; Ryan accelerated
|
| 7/20/2020 | CLHY | Market Commentary: Epicor term loans see strong demand; Alion Science & Technology firms terms
|
| 7/16/2020 | CLHY | Market Commentary: MyEyeDr. updates pricing; Alion accelerated; Epicor, Tosca Services guidance surfaces
|
| 7/14/2020 | CLHY | Market Commentary: Authentic Brands deal revisions emerge; Sequa seeks extension, pre-placed term loan
|
| 8/22/2018 | BKCVHY | S&P affirms Epicor
|
| 6/21/2018 | CLHY | Market Commentary: Energizer, DXP, Ryman, Epicor break; Kindred, Novolex, Electrical Components, iStar update
|
| 6/18/2018 | CLHY | Market Commentary: Solenis, Tradesmen, Minimax break; Sound Inpatient, Tenneco tweaked; Invenergy accelerated
|
| 2/15/2018 | HYLM | Epicor to redeem $100 million of floating-rate notes due 2023
|
| 8/15/2017 | CLHY | Market Commentary: Staples, Big River, Curo Health, Nature’s Bounty, Novolex, Vistra Energy, Epicor break
|
| 8/9/2017 | CLHY | Market Commentary: Sabre, Constellis, Polyconcept break; Staples, United Site, ATI, Sparta, TMS revise deals
|
| 8/11/2016 | CLHY | Market Commentary: XPO, Polyconcept, Continental Building, Headwaters, WaveDivision free to trade; Valeant dips
|
| 8/11/2016 | BKCVHY | Moody’s assigns B3 to Epicor Software
|
| 7/6/2016 | BKCVHY | S&P puts Epicor on developing watch
|
| 7/5/2016 | CLHY | Market Commentary: Epicor term loan strengthens with buyout news; Arbor Pharmaceuticals outlines term B changes
|
| 6/5/2015 | HY | New Issue: Epicor Software prices $610 million second-lien notes due 2023 at par
|
| 5/21/2015 | CLHY | Market Commentary: Epicor, Virgin Media, Weather, Infiltrator, Hubbard Radio, LegalShield, Bombardier break
|
| 5/18/2015 | BKCVHY | S&P cuts Epicor view, rates loans B, CCC+
|
| 5/18/2015 | BKHY | Moody’s cuts Epicor, rates loans B2, Caa2
|
| 5/12/2015 | CLHY | Market Commentary: Air Canada, Raley’s break; Epicor, Merrill, Flint, Hubbard, American Gaming, CHG set talk
|
| 5/11/2015 | CLHY | Market Commentary: Houghton, Penton, Accuvant, Gold Standard, A. Schulman break; TransDigm, PSAV revised
|
| 8/27/2014 | BKCVDDHY | S&P: Epicor view to stable
|
| 6/30/2014 | BKCVDDHY | Moody’s upgrades Epicor, debt
|
| 6/5/2013 | HY | Market Commentary: Midday Commentary: Drive-by activity slows amid heavy market conditions; ETF trading active
|
| 6/4/2013 | HY | Market Commentary: Primary focus shifts to Europe; Barry Callebaut slates; overall junk market remains weak
|
| 6/3/2013 | BKCVDDHY | Moody's assigns Caa2 to Epicor notes
|
| 6/3/2013 | HY | Epicor $350 million five-year PIK toggle coupon talk is 9% cash, 93/4% PIK at 98 area
|
| 6/3/2013 | HY | New Issue: Epicor upsizes to $400 million, prices 9%/93/4% PIK toggle notes at 98
|
| 6/3/2013 | HY | Market Commentary: New month begins quietly as calendar builds; RBS does split-rated deal; overall market heavier
|
| 6/3/2013 | BKCVDDHY | S&P cuts Epicor Software view, rates notes CCC+
|
| 11/20/2012 | HY | Market Commentary: American Piping prices; recent deals firm in quiet market; J.C. Penney shrugs off downgrade
|
| 11/16/2012 | HY | Market Commentary: Studio City, Walter, Pacific Drilling, Thompson Creek price to cap $5 billion primary week
|
| 11/15/2012 | HY | Market Commentary: AmSurg, Alliance, GrafTech, Sealed Air price, Bombardier drops out; funds lose $1.3 billion
|
| 11/14/2012 | HY | Epicor Software withdraws $340 million discount notes offering
|
| 11/14/2012 | HY | Market Commentary: Arch, Antero, AK, Ainsworth price, Bombardier on tap; Epicor pulls discount notes deal
|
| 11/9/2012 | BKCVDDHY | Moody's cuts Epicor, rates notes Caa2
|
| 11/9/2012 | HY | Market Commentary: Primary stays strong as Perstorp sells $1.1 billion; Sprint down; Cengage pummeled on earnings
|
| 11/8/2012 | HY | Market Commentary: Sprint sells $2.28 billion; coupon question for Edison; James River off; funds up $82 million
|
| 11/8/2012 | BKDDHY | S&P rates Epicor notes CCC+
|
| 11/8/2012 | HY | Eagle Midco sets Friday investor call for $340 million discount notes
|
| 6/25/2012 | BKCVHY | S&P lifts Epicor to stable
|
| 7/13/2011 | BKCVDDHY | S&P rates Epicor loan B+
|
| 5/11/2011 | HY | New Issue: Epicor/Activant prices $465 million 8 5/8% eight-year notes at par
|
| 5/11/2011 | HY | Market Commentary: Range drive-by, Unit, Epicor price, EchoStar, First Wind, Exopack slate; Jaguar deal ahead
|
| 5/10/2011 | HY | Market Commentary: Delphi, drive-by NRG mega-deals price, Linn Energy also; Ardagh slates; Caesars up on results
|
| 5/10/2011 | HY | Epicor/Activant talks $465 million eight-year notes at 83/4% area yield
|
| 5/4/2011 | BKCVHY | Moody's: Epicor-Activant B2, loans Ba3, notes Caa1
|
| 5/3/2011 | HY | Epicor/Activant intend to start roadshow Wednesday for $465 million eight-year senior notes
|
| 5/3/2011 | HY | Market Commentary: Upsized Charter drive-by, Shea Homes, Speedy Cash deals price; new Shea, Speedy deals trade up
|
| 4/11/2011 | BKHY | Epicor Software plans $945 million credit facility, $465 million bonds
|
| 4/4/2011 | BKHY | Combination of Epicor and Activant to be funded with loan, notes
|
| 12/19/2007 | BKCVHY | S&P cuts Epicor loans to B
|
| 12/17/2007 | BKCVHY | Moody's: Epicor unchanged
|
| 12/10/2007 | BKCVHY | Moody's affirms Epicor
|
| 5/17/2007 | BKCVHY | S&P rates Epicor notes B+
|
| 4/19/2007 | BKCVHY | S&P boosts Epicor
|
| 3/20/2006 | BKCVHY | Moody's rates Epicor SGL-1, loans B1
|
